104 results
Page 3 of 6
DEFM14A
odfupe3biehw8
29 Apr 20
Proxy related to merger
3:20pm
CORRESP
fzg1o9 ubksh
27 Apr 20
Correspondence with SEC
12:00am
UPLOAD
7e8kzkwkv
24 Apr 20
Letter from SEC
12:00am
PRER14A
2bz66 dt0
10 Apr 20
Preliminary revised proxy
4:38pm
CORRESP
io3qdbw
10 Apr 20
Correspondence with SEC
12:00am
UPLOAD
l7qqf
6 Apr 20
Letter from SEC
12:00am
8-K
3z1evtl hezigm4t0qp
9 Mar 20
Entry into a Material Definitive Agreement
12:00am
DEFA14A
i1ako3
9 Mar 20
Additional proxy soliciting materials
12:00am
PREM14A
4o44gs2nna 6vkjpn4b
6 Mar 20
Preliminary proxy related to merger
5:32pm
8-K
EX-99.1
hhlc0bl
5 Mar 20
Zafgen Reports Fourth Quarter and Full Year 2019 Financial Results
4:16pm
DEFA14A
u9sdus
5 Feb 20
Additional proxy soliciting materials
4:31pm
8-K
EX-99.1
fsgczm06f
5 Feb 20
Regulation FD Disclosure
4:30pm
8-K
EX-99.1
wkxbqil f4
13 Jan 20
Regulation FD Disclosure
7:17am
DEFA14A
EX-99.1
m4n4pk9 qqii3d
13 Jan 20
Additional proxy soliciting materials
7:15am
DEFA14A
nh7vrbw47 pium
18 Dec 19
Additional proxy soliciting materials
4:31pm
8-K
14wlgr2y
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
8-K
EX-99.3
u68n e37vgr7u61nd6
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am